跳至主要内容
临床试验/NCT00691171
NCT00691171已完成不适用

Using an Electronic Health Record-based Intervention and Broad Education Reach Strategies to Improve Quality of Care for GERD and Gastroprotection for Patients on NSAIDs: a Randomized Controlled Trial

AstraZeneca0 个研究点目标入组 5,234 人开始时间: 2007年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
5,234
主要终点
Diagnoses of GERD

研究概览

简要总结

The purpose of the study is to examine the impact of augmented, high-quality physician-coordinated care executed via an electronic health record (EHR)-based intervention on quality of care for gastroesophageal reflux disease (GERD) and for gastroprotection for patients on chronic non-steroidal anti-inflammatory drugs (NSAIDs) at increased risk for upper GI tract ulcers and ulcer related complications.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Eligibility as determined by criteria for participation in studies as part of the MQIC
  • Agreement of participating clinical practices to undergo training in the electronic health record (EHR) intervention designed for this study

排除标准

  • Based on voluntary participation by MQIC practices, so practices were excluded if they decided to opt out

结局指标

主要结局

Diagnoses of GERD

时间窗: After 12 months of intervention

Prescriptions for gastroprotective medicines in at-risk, chronic NSAID users

时间窗: After 12 months of intervention

次要结局

  • NSAID-related GI complications(After 12 months of intervention)
  • Change in GERD symptoms score(After 12 months of intervention)
  • Prescriptions for GERD medications(After 12 months of intervention)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

相似试验

Electronic Health Record (EHR)-Based Intervention... | 临床试验